ArticleAdvanced healthcare materials2026
Electro-Stimulated Graphene-Polymer Nanocomposites Enable Wearable Patches With Feedback-Controlled Drug Release.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stimuli-responsive nanomaterials capable of spatiotemporal control over drug release are of nanocomposite patch ("e-Medi-Patch") engineered from biodegradable polycaprolactone (PCL), graphene nanoplatelets, and a redox-active therapeutic, niclosamide. The hierarchical composite integrates π-π interactions between aromatic drug molecules and conductive graphene to enhance loading and retention, an Au microelectrode interface to enable wireless electrostimulation, and bluetooth-assisted impedance sensing for real-time monitoring of release dynamics. Under mild electrical stimulation, the nanocomposite exhibits on-demand, unidirectional release of niclosamide with tunable kinetics, confirmed by modelling, in vitro melanoma cell studies, and in vivo xenograft tumor regression. Unlike conventional slow-release patches that rely on passive diffusion, the e-Medi-Patch uniquely offers on-demand electrostimulatory release with real-time feedback monitoring, transforming drug delivery from a static system into an actively controlled, intelligent therapeutic platform. Beyond melanoma, the platform accommodates other redox-active therapeutics and offers scalable melt-blending fabrication. This work establishes an integrated materials-electronics strategy for wearable, feedback-controlled drug delivery, bridging multifunctional nanocomposites and precision medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.